Identification of Triple-negative and Basal-like Canine Mammary Carcinomas using Four Basal Markers
Authors:
- H.Y. LimHLH.Y. Lim
- K.S. ImKIK.S. Im
- J.H. KimJ.H. Kim
- J.-H. SurJ.-H. Sur
- 1 May 2013
- journal article
- Published by Elsevier in Journal of Comparative Pathology
- Vol. 148 (4) , 298-306
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Science and Technology (2011-0021337)
- National Research Foundation of Korea
This publication has 38 references indexed in Scilit:
- Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal SubtypesClinical Cancer Research, 2009
- How basal are triple‐negative breast cancers?International Journal of Cancer, 2008
- Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative PhenotypeClinical Cancer Research, 2008
- Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypesHuman Pathology, 2006
- Concordance among Gene-Expression–Based Predictors for Breast CancerNew England Journal of Medicine, 2006
- p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomasVirchows Archiv, 2005
- Expression of luminal and basal cytokeratins in human breast carcinomaThe Journal of Pathology, 2004
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences, 2001
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991